Personalized Dosing Protocols Based on Body Composition
Some trials and community guides scale peptide doses by body weight or lean mass. This page covers how that math works and what hasn't been tested as of October 2026.
Introduction
Personalized dosing accounts for individual variation in body composition and response. Some trials do this formally, and community guides borrow the idea (see how to read reported peptide doses).
Factors Affecting Dosing
Body Weight and Composition
- Lean mass vs. total weight
- Fat mass percentage
Age and Metabolism
- Natural hormone levels decline with age
- Basal metabolic rate and thyroid function
Weight-Based Dosing
General Guidelines
Some community guides use mcg/kg tiers like these, which we couldn't trace to any trial:
- Conservative: 1-2 mcg/kg body weight
- Standard: 2-3 mcg/kg body weight
- Aggressive: 3-4 mcg/kg body weight
Trials look different. A 1999 study of ipamorelin (evidence level: moderate) gave healthy men 15-minute IV infusions of 4.21 to 140.45 nmol/kg, which don't map onto the tiers above. Blood levels tracked dose, but the growth hormone response varied more between people.
Examples by Weight
Tier arithmetic only, not a recommendation:
| Body Weight | Conservative | Standard | Aggressive |
|---|---|---|---|
| 70 kg (154 lb) | 70-140 mcg | 140-210 mcg | 210-280 mcg |
| 85 kg (187 lb) | 85-170 mcg | 170-255 mcg | 255-340 mcg |
| 100 kg (220 lb) | 100-200 mcg | 200-300 mcg | 300-400 mcg |
Lean Mass Adjustment
Some guides use lean mass for dosing calculations instead, as more precise than total weight. A 2005 pharmacokinetics paper noted that lean bodyweight has been recommended for scaling drug doses, though common estimates are inconsistent at extremes of size. We found no peptide study of this.
Adjusting Based on Response
These signs come from community guides.
Signs of Under-Dosing
- Minimal noticeable effects
- No side effects (not always informative)
Signs of Over-Dosing
- Excessive side effects
- Water retention
- Sleep disturbances
- Anxiety or mood changes
Titration Protocol
Guides describe this untested scheme:
- A conservative first dose
- Assessment for 2 weeks
- A 25% increase if tolerated
- Repeated increases until the desired response or side effects
Special Populations
High Body Fat
Some guides say this group may need higher doses for effect; lean-mass math would give a smaller one.
Low Body Fat and Older Users
Guides describe both as often more sensitive and favor lower starts. We found no peptide data on either.
What we still don't know
Whether starting conservative and adjusting based on response is the safest approach hasn't been studied. If a vial's content differs from its label, every mcg/kg figure is off too (see peptide sourcing and quality control).
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.